López Bastida Julio, Oliva Juan, Antoñanzas Fernando, García-Altés Anna, Gisbert Ramón, Mar Javier, Puig-Junoy Jaume
Servicio Canario de Salud, Unidad de Planificación y Evaluación, Santa Cruz de Tenerife, Spain.
Gac Sanit. 2010 Mar-Apr;24(2):154-70. doi: 10.1016/j.gaceta.2009.07.011. Epub 2009 Dec 2.
Over the last few years, economic evaluation of health technologies has become a major tool used by European health policy decision-makers to create strategies for prioritizing the allocation of health resources and the approval of new technologies. Spain was a pioneer in proposing the standardization of methodology applicable to economic evaluation studies. However, because health policy decision-makers refused to support the initiative, the methodology was never put into practice. In the medium term, evidence of the economic value of new health technologies financed by the national health system will probably be increasingly required. At that time, stakeholders and decision-makers will have to agree upon a clear and concise set of rules on the technical and methodological issues that must be followed by economic evaluations of health technologies. Consequently, we have provided guidelines and recommendations for producing first-rate economic evaluations. The recommendations appear under seventeen headings or sections. In each case, the recommended requirements to be satisfied by an economic evaluation of health technologies are provided and each recommendation is followed by a commentary, providing a justification and comparing and contrasting the proposal with other available alternatives.
在过去几年中，卫生技术的经济评估已成为欧洲卫生政策决策者用于制定卫生资源分配优先战略和批准新技术的主要工具。西班牙在提议适用于经济评估研究的方法标准化方面处于领先地位。然而，由于卫生政策决策者拒绝支持该倡议，该方法从未付诸实践。从中期来看，可能会越来越需要由国家卫生系统资助的新卫生技术的经济价值证据。届时，利益相关者和决策者将必须就卫生技术经济评估必须遵循的一套关于技术和方法问题的清晰简洁的规则达成一致。因此，我们提供了有关进行一流经济评估的指南和建议。这些建议列在十七个标题或章节下。在每种情况下，都提供了卫生技术经济评估应满足的建议要求，并且每条建议之后都有一篇评论，提供理由并将该提议与其他可用选择进行比较和对比。
